This inventor holds 0 USPTO granted patents, plus 14 CIPO patents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: Evangelos Karavas: Innovator in Pharmaceutical Compositions
Introduction
Evangelos Karavas is a notable inventor based in Greece, recognized for his contributions to the field of pharmaceuticals. His work primarily focuses on developing innovative compositions that enhance therapeutic efficacy.
Latest Patents
Karavas holds several patents, including a significant invention titled "Pharmaceutical Compositions Comprising A Fumaric Acid Ester And Method For The Preparation Thereof." This invention relates to a delayed release pharmaceutical composition that includes a fumaric acid ester, such as Dimethyl fumarate, formulated as gastro-resistant tablets filled into hard gelatin capsules. Another noteworthy patent is "Ophthalmic Pharmaceutical Composition Containing A Carbonic Anhydrase Inhibitor And Method For The Preparation Thereof." This invention describes a stable pharmaceutical formulation for topical administration, which contains a therapeutically effective quantity of Brinzolamide or its ophthalmologically acceptable salts, along with a surfactant like poloxamer, aimed at treating ocular hypertension and glaucoma.
Career Highlights
Throughout his career, Karavas has worked with prominent companies in the pharmaceutical industry, including Pharmathen S.A. and Expermed S.A. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.
Collaborations
Karavas has collaborated with several professionals in his field, including Efthymios Koutris and Sotiria Haitidou. These collaborations have likely enriched his research and development efforts.
Conclusion
Evangelos Karavas is a dedicated inventor whose work in pharmaceutical compositions demonstrates his commitment to advancing medical science. His innovative patents and collaborations reflect his significant contributions to the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile